A Broadly Protective Vaccine against Globally Dispersed Clade 1 and Clade 2 H5N1 Influenza Viruses
Open Access
- 15 April 2008
- journal article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 197 (8) , 1185-1188
- https://doi.org/10.1086/529522
Abstract
Development of effective and immunogenic vaccines against highly pathogenic avian influenza H5N1 viruses with the potential to cause a pandemic is aKeywords
This publication has 15 references indexed in Scilit:
- New Pre-pandemic Influenza Vaccines: An Egg- and Adjuvant-independent Human Adenoviral Vector Strategy Induces Long-lasting Protective Immune Responses in MiceClinical Pharmacology & Therapeutics, 2007
- Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trialThe Lancet, 2007
- Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trialThe Lancet, 2006
- Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trialThe Lancet, 2006
- Safety and Immunogenicity of an Inactivated Subvirion Influenza A (H5N1) VaccineNew England Journal of Medicine, 2006
- Protection of Mice and Poultry from Lethal H5N1 Avian Influenza Virus through Adenovirus-Based ImmunizationJournal of Virology, 2006
- Establishment of multiple sublineages of H5N1 influenza virus in Asia: Implications for pandemic controlProceedings of the National Academy of Sciences, 2006
- Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in miceThe Lancet, 2006
- Detection of anti-H5 responses in human sera by HI using horse erythrocytes following MF59-adjuvanted influenza A/Duck/Singapore/97 vaccineVirus Research, 2004
- A High-Efficiency Cre/loxP-Based System for Construction of Adenoviral VectorsHuman Gene Therapy, 1999